Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment

被引:54
作者
Christian, Kyle J. [1 ]
Lang, Matti A. [1 ]
Raffalli-Mathieu, Francoise [2 ]
机构
[1] Uppsala Univ, Ctr Biomed, Div Pharmaceut Biochem, S-75123 Uppsala, Sweden
[2] Uppsala Univ, Ctr Biomed, Dept Biochem & Org Chem, S-75123 Uppsala, Sweden
关键词
D O I
10.1124/mol.107.042507
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We describe a novel cis-element in the 5' coding region of p53 mRNA and its interaction with heterogeneous nuclear ribonucleoprotein (hnRNP) C1/C2. This element is located in a putative hairpin loop structure, within the first 101 nucleotides downstream of the start codon. The binding of hnRNPC1/C2 is strongly enhanced in response to the DNA-damaging drug cisplatin [cis-diamminedichloroplatinum(II)] and the cytostatic transcriptional inhibitor actinomycin D (dactinomycin), both known inducers of apoptosis and p53. Strongly stimulated binding is observed in both nuclear and cytoplasmic compartments, and it is accompanied by a cytoplasmic increase of hnRNPC1/C2. Changes in hnRNPC1/C2 protein levels are not proportional to binding activity, suggesting qualitative changes in hnRNPC1/C2 upon activation. Phosphorylation studies reveal contrasting characteristics of the cytoplasmic and nuclear hnRNPC1/C2 interaction with p53 mRNA. Results from chimeric p53-luciferase reporter constructs suggest that hnRNPC1/C2 regulates p53 expression via this binding site. Our results are consistent with a mechanism in which the interaction of hnRNPC1/C2 with a cis-element within the coding region of the p53 transcript regulates the expression of p53 mRNA before and during apoptosis. In addition, we report that preapoptotic signals induced by transcriptional inhibition trigger the appearance of a truncated, exclusively cytoplasmic 43-kDa variant of p53 before apoptosis.
引用
收藏
页码:1558 / 1567
页数:10
相关论文
共 40 条
[1]   Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents [J].
Achanta, G ;
Huang, P .
CANCER RESEARCH, 2004, 64 (17) :6233-6239
[2]   Inhibition of Transcription Results in Accumulation of Wt p53 Followed by Delayed Outburst of p53-Inducible Proteins: p53 as a Sensor of Transcriptional Integrity [J].
Blagosklonny, Mikhail V. ;
Demidenko, Zoya N. ;
Fojo, Tito .
CELL CYCLE, 2002, 1 (01) :67-74
[3]   PRIMARY STRUCTURES OF THE HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2-PROTEIN, B1-PROTEIN, AND C2-PROTEIN - A DIVERSITY OF RNA-BINDING PROTEINS IS GENERATED BY SMALL PEPTIDE INSERTS [J].
BURD, CG ;
SWANSON, MS ;
GORLACH, M ;
DREYFUSS, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9788-9792
[4]   Interaction of heterogeneous nuclear ribonucleoprotein A1 with cytochrome P450 2A6 mRNA:: Implications for post-transcriptional regulation of the CYP2A6 gene [J].
Christian, K ;
Lang, M ;
Maurel, P ;
Raffalli-Mathieu, F .
MOLECULAR PHARMACOLOGY, 2004, 65 (06) :1405-1414
[5]   HNRNP PROTEINS AND THE BIOGENESIS OF MESSENGER-RNA [J].
DREYFUSS, G ;
MATUNIS, MJ ;
PINOLROMA, S ;
BURD, CG .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :289-321
[6]   Participation of the human p53 3'UTR in translational repression and activation following gamma-irradiation [J].
Fu, LN ;
Benchimol, S .
EMBO JOURNAL, 1997, 16 (13) :4117-4125
[7]   Identification and characterization of a 44 kDa protein that binds specifically to the 3'-untranslated region of CYP2a5 mRNA: Inducibility, subcellular distribution and possible role in mRNA stabilization [J].
Geneste, O ;
Raffalli, F ;
Lang, MA .
BIOCHEMICAL JOURNAL, 1996, 313 :1029-1037
[8]   Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the national Wilms tumor study group [J].
Green, Daniel M. ;
Cotton, Cecilia A. ;
Malogolowkin, Marcio ;
Breslow, Norman E. ;
Perlman, Elizabeth ;
Miser, James ;
Ritchey, Michael L. ;
Thomas, Patrick R. M. ;
Grundy, Paul E. ;
D'Angio, Giulio J. ;
Beckwith, J. Bruce ;
Shamberger, Robert C. ;
Donaldson, Milton ;
Weetman, Robert ;
Coppes, Max J. ;
Shearer, Patricia ;
Coccia, Peter ;
Kletzel, Morris ;
Macklis, Roger ;
Tomlinson, Gail ;
Huff, Vicki ;
Newbury, Robert ;
Weeks, Douglas .
PEDIATRIC BLOOD & CANCER, 2007, 48 (05) :493-499
[9]  
HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881
[10]   Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen [J].
Hauer, Julia ;
Graubner, Ulrike ;
Konstantopoulos, Nikos ;
Schmidt, Susanne ;
Pfluger, Thomas ;
Schmid, Irene .
PEDIATRIC BLOOD & CANCER, 2007, 49 (06) :852-854